Melatonin ameliorates oxidative damage induced by maternal lead exposure in rat pups

Maryam Bazrgar1, Iran Goudarzi1, Taghi Lashkarbolouki1

  • 1School of Biology, Damghan University, Damghan, Iran.

Physiology & Behavior
|July 22, 2015
PubMed

Insights

Lead exposure harms cerebellum development and neuron health. Melatonin treatment protected developing rat brains by reducing oxidative stress and improving motor function, suggesting its therapeutic potential against lead toxicity.

Area of Science:

  • Neuroscience
  • Toxicology
  • Developmental Biology

Background:

  • Lead (Pb) exposure during development impairs cerebellum growth and causes neuron loss.
  • Pb toxicity is a significant global public health concern requiring effective prevention strategies.
  • Melatonin, a potent antioxidant, is investigated for its neuroprotective effects.

Purpose of the Study:

  • To evaluate melatonin's efficacy against lead-induced neurotoxicity and oxidative stress in the developing cerebellum.
  • To assess the impact of melatonin on antioxidant enzyme activity and lipid peroxidation markers.
  • To determine melatonin's effect on motor function and cerebellar histology following lead exposure.

Main Methods:

  • Rats were exposed to lead acetate from gestation day 5 through weaning.
  • Melatonin (10mg/kg) was administered daily to assess its protective effects.
  • Antioxidant enzyme activities (SOD, GPx), lipid peroxidation (TBARS), motor behavior (rotarod, locomotor tests), and Purkinje cell counts were analyzed.

Main Results:

  • Lead exposure increased lipid peroxidation and TBARS levels while decreasing SOD and GPx activities in the cerebellum.
  • Pb-exposed rats exhibited impaired motor performance and reduced Purkinje cell counts.
  • Melatonin treatment significantly counteracted these effects, restoring antioxidant levels, reducing lipid peroxidation, and improving motor deficits.

Conclusions:

  • Melatonin effectively mitigates lead-induced oxidative stress and neurotoxicity in the developing cerebellum.
  • Melatonin treatment prevents motor impairments and Purkinje cell loss associated with lead exposure.
  • These findings highlight melatonin's potential as a therapeutic agent for protecting against lead neurotoxicity.

Related Concept Videos